← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Neonc Technologies, Inc.
Inglewood, CA
$2,345,060
Total funding
5
Grants
Funding over time
peak $1.4M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,345,060 · 5
By mechanism
R41$1,337,448 · 4
R42$1,007,612 · 1
Investigators at Neonc Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Developing a Clinically Relevant Radiosensitizer for Temozolomide-resistant Gliomas$1,007,612
R42 · FY2025 · CA
Development of NEO212, A Novel Oral Drug for the Treatment of Acute Myeloid Leukemia$399,998
R41 · FY2025 · CA
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas$336,000
R41 · FY2020 · CA
Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100$300,000
R41 · FY2018 · CA
Temozolomide Perillyl Alcohol Conjugate as Treatment for Recurrent Malignant Brain tumors$300,000
R41 · FY2016 · CA
Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100$1,450
R41 · FY2019 · CA